N-Acetyl procainamide

Revision as of 18:43, 27 September 2011 by WikiBot (talk | contribs) (Protected "N-Acetyl procainamide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
N-Acetyl procainamide
File:N-Acetyl procainamide.svg
Clinical data
Routes of
administration
intravenously or orally
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H23N3O2
Molar mass277.36 g/mol

N-Acetylprocainamide (NAPA) (or acecainide) is the N-acetylated metabolite of procainamide. It is a Class III antiarrhythmic agent.

It can be given either intravenously or orally, and is eliminated primarily by renal excretion. Comparative studies with other antiarrhythmic drugs have not been undertaken apart from a small study in atrial flutter where acecainide was better than quinidine plus digoxin. Thus, although further clinical experience is required before the relative place of acecainide in therapy can be determined, the drug nevertheless appears to offer advantages over procainamide, particularly with respect to the reduced formation of antinuclear antibodies.

References

  • Merck Index, 13th Edition, 20.
  • Ger. Pat. , 1971, 2 062 978; CA , 75 , 76427, (Acecainide)

Template:Pharm-stub


Template:WikiDoc Sources